{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:33:40Z","timestamp":1773797620175,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.oftal.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T22:23:00Z","timestamp":1513462980000},"page":"225-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Corticoterapia vs. corticoterapia con inmunosupresores en el tratamiento de la fase aguda del s\u00edndrome de Vogt-Koyanagi-Harada"],"prefix":"10.1016","volume":"93","author":[{"given":"L.E.","family":"Concha-del R\u00edo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Arellanes-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2017.09.010_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9394(14)75078-0","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"90","author":"Synder","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"39","author":"Moorthy","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0115","first-page":"9","article-title":"Vogt-Koyanagi-Harada disease","volume":"22","author":"Sugira","year":"1978","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0120","first-page":"596","article-title":"[Analysis of the candidate antigen for Harada's disease]","volume":"98","author":"Kondo","year":"1994","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.oftal.2017.09.010_bib0125","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/bjo.80.11.1002","article-title":"Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease","volume":"80","author":"Norose","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-1549(02)00025-1","article-title":"Vogt-Koyanagi-Harada disease","volume":"15","author":"Read","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.oftal.2017.09.010_bib0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000310145","article-title":"Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease","volume":"201","author":"Samamoto","year":"1990","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oftal.2017.09.010_bib0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","article-title":"Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease","volume":"142","author":"Read","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0155","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","article-title":"Vogt-Koyanagi-Harada syndrome. Clinical course, therapy and long-term visual outcome","volume":"109","author":"Rubsamen","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0160","first-page":"1","article-title":"Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease","author":"Lai","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.oftal.2017.09.010_bib0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10792-007-9159-1","article-title":"Management of ocular complications of Vogt-Koyanagi-Harada syndrome","volume":"29","author":"Perente","year":"2009","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oftal.2017.09.010_bib0175","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1111\/j.1755-3768.2012.02498.x","article-title":"The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"90","author":"Abu El-Asrar","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.oftal.2017.09.010_bib0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10792-006-9009-6","article-title":"Spectrum of Vogt-Koyanagi-Harada in Singapore","volume":"27","author":"Chee","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10792-007-9062-9","article-title":"Prognostic factors in Vogt-Koyanagi-Harada disease","volume":"27","author":"Al-Karashi","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0002-9394(01)00937-0","article-title":"Complications and prognostic factors in Vogt-Koyanagi-Harada disease","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0195","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/aos.12127","article-title":"Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high dose corticosteroids","volume":"91","author":"Abu El-Asrar","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oftal.2017.09.010_bib0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09273940701624312","article-title":"The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease","volume":"15","author":"Kim","year":"2007","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117303222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117303222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T06:33:11Z","timestamp":1535178791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669117303222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0365669117303222"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2017.09.010","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticoterapia vs. corticoterapia con inmunosupresores en el tratamiento de la fase aguda del s\u00edndrome de Vogt-Koyanagi-Harada","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}